AVTR vs BIO: stock comparison and AI forecast
Avantor, Inc. (AVTR) and Bio-Rad Laboratories, Inc. (BIO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVTR Avantor, Inc.
- Market Cap
- $10.56B
- P/E Ratio
- 27.8x
- Size
- large-cap
- AI Forecast
BIO Bio-Rad Laboratories, Inc.
- Market Cap
- $10.02B
- P/E Ratio
- 45.8x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AVTR and BIO have similar market capitalizations ($10.56B and $10.02B).
- AVTR trades at 27.8 times trailing earnings, BIO at 45.8 times.
- BIO turns 8.6% of its revenue into net income, against 5.1% for AVTR.
- AVTR carries 0.99 times debt per unit of equity, against 0.43 times for BIO.
- Both companies share the SEC industry classification Laboratory Analytical Instruments.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVTR | BIO |
|---|---|---|
| Market Cap | $10.56B | $10.02B |
| P/E Ratio | 27.84x | 45.77x |
| P/B Ratio | 1.81x | 1.40x |
| EPS | $0.56 | $8.19 |
| Book Value/Share | $8.61 | $268.30 |
| Revenue/Share | $9.79 | $96.84 |
| FCF/Share | $0.65 | $13.21 |
Profitability & Margins
| Metric | AVTR | BIO |
|---|---|---|
| ROE | 5.8% | 3.1% |
| ROA | 2.9% | 2.2% |
| ROIC | 4.8% | 0.6% |
| Gross Margin | 31.6% | 51.9% |
| Operating Margin | 7.3% | 2.0% |
| Net Margin | 5.1% | 8.6% |
| EBT Margin | 4.8% | 13.5% |
| Tax Rate | -6.9% | 36.5% |
Financial Health
| Metric | AVTR | BIO |
|---|---|---|
| Current Ratio | 1.89x | 3.14x |
| Quick Ratio | 1.27x | 2.33x |
| D/E Ratio | 0.99x | 0.43x |
| Financial Leverage | 1.99x | 1.43x |
| Interest Coverage | 3.5x | 6.0x |
| Working Capital | $1.22B | $2.06B |
Cash Flow
| Metric | AVTR | BIO |
|---|---|---|
| Operating Cash Flow | $585M | $493M |
| Free Cash Flow | $439M | $353M |
| Capital Spending | -$146M | -$140M |
| OCF Growth YoY | -9.3% | -7.8% |
| FCF Growth YoY | -16.1% | -4.8% |
| FCF/Sales | 6.6% | 13.6% |
| CapEx/Sales | 2.2% | 5.4% |
Operational Efficiency
| Metric | AVTR | BIO |
|---|---|---|
| Asset Turnover | 0.57x | 0.25x |
| Receivables Turnover | 5.9x | 5.9x |
| Inventory Turnover | 5.3x | 1.6x |
| Fixed Assets Turnover | 8.5x | 5.0x |
| Days Sales Outstanding | 62 days | 62 days |
| Days Inventory | 69 days | 229 days |
| Payables Period | 59 days | 42 days |
| Cash Conversion Cycle | 71 days | 249 days |
Income Statement
| Metric | AVTR | BIO |
|---|---|---|
| Total Revenue | $6.64B | $2.59B |
| Operating Income | $487M | $53M |
| Net Income | $337M | $222M |
| R&D Expense | – | $266M |
| SG&A Expense | $1.60B | $852M |
| Cost of Goods Sold | $4.54B | $1.25B |
Dividend & Shareholder Information
| Metric | AVTR | BIO |
|---|---|---|
| Shares Outstanding | 678M | 27M |
| Net Income Growth | – | -30.3% |
| EPS Growth | – | -84.0% |
AVTR vs BIO: stock comparison and AI forecast
Which is bigger, AVTR or BIO?
AVTR and BIO have similar market capitalizations ($10.56B and $10.02B).
Which is cheaper on earnings, AVTR or BIO?
AVTR trades at 27.8 times trailing earnings, BIO at 45.8 times.
Which one does Intratio's AI model rank higher, AVTR or BIO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.